Disclosed are 3'-N-desmethyl-3'-N-substituted-6-O-methyl-11,12-cyclic carbamate erythrolide A derivatives of formula (I) which are antagonists of luteinizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.
